Mechanism of Xu Li's Experiential Prescription for the Treatment of EGFR-Positive NSCLC

The non-small-cell lung cancer (NSCLC) is the most common lung cancer which seriously threatens the human health. Xu Li's experiential prescription (XLEP) can treat the NSCLC. However, whether XLEP can regulate the autophagy in the EGFR-positive NSCLC still remains unknown. We found that the ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Bin, Zhang, Haitao, Wang, Yuchao, Huang, Shuran, Xu, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091530/
https://www.ncbi.nlm.nih.gov/pubmed/32256661
http://dx.doi.org/10.1155/2020/8787153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091530/
https://www.ncbi.nlm.nih.gov/pubmed/32256661
http://dx.doi.org/10.1155/2020/8787153

Ejemplares similares